Reuters logo
BRIEF-CRISPR Therapeutics appoints Michael Tomsicek as CFO
November 13, 2017 / 1:13 PM / in 9 days

BRIEF-CRISPR Therapeutics appoints Michael Tomsicek as CFO

Nov 13 (Reuters) - CRISPR Therapeutics AG

* CRISPR Therapeutics announces appointment of Michael Tomsicek as Chief Financial Officer

* CRISPR Therapeutics AG - ‍ prior to joining CRISPR Therapeutics, Tomsicek most recently served as CFO of Abiomed​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below